Form 8-K - Current report:
SEC Accession No. 0001628280-26-053940
Filing Date
2026-08-06
Accepted
2026-08-06 08:49:15
Documents
14
Period of Report
2026-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brns-20260806.htm   iXBRL 8-K 31533
2 EX-99.1 brns-20260630xexx991.htm EX-99.1 153885
7 a1a.jpg GRAPHIC 5260
  Complete submission text file 0001628280-26-053940.txt   377679

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT brns-20260806.xsd EX-101.SCH 2640
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT brns-20260806_def.xml EX-101.DEF 16956
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT brns-20260806_lab.xml EX-101.LAB 30136
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT brns-20260806_pre.xml EX-101.PRE 17814
18 EXTRACTED XBRL INSTANCE DOCUMENT brns-20260806_htm.xml XML 4232
Mailing Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874
Business Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 261246526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)